Blain: The World Changed...
Coronavirus treatments: keep your eye on anti-complement drugs – they look promising
Pfizer Kicks Off Covid-19 Vaccine Pilot Delivery Program In US - Report
Why COVID-19 Testing Is A Tragic Waste
STAT honors ‘Wunderkind’ for pioneering work at UVA on focused ultrasound, cancer
Could an antidepressant be used to treat COVID-19?
J&J Secures Additional $1 Billion in Funding for Covid-19 Vaccine
Secondhand clothing sales are booming – and may help solve the sustainability crisis in the fashion industry
What monoclonal antibodies are – and why we need them as well as a vaccine
Agilent’s Diagnostic Tool Wins FDA Nod For Use In Breast Cancer Patients
Roche’s Herceptin/Perjeta combo product nears EU approval
ISPOR Europe Panel: “Will COVID-19 Accelerate the Adoption of Digital Health Technologies?”
FDA Approves Keytruda for Triple‑Negative Breast Cancer
Human Capital: Amazon and CZI face labor disputes as Biden promises gig workers better protections
COVID-19 vaccine update: Pfizer may be the frontrunner, but Canada has hedged its bets
This Week in Apps: Conservative apps surge, Instagram redesigned, TikTok gets ghosted
Aurinia Stock to Surge by 80%? This 5-Star Analyst Thinks It's Possible
Study: Respiratory failure in COVID-19 usually not driven by cytokine storm
Elastic-free face masks can help some with allergies stay safe during COVID-19
Researchers identify promising new compounds to potentially treat novel coronaviruses
World’s top intensive care body advises against remdesivir for sickest Covid patients
How Effective Will Lilly’s Bamlanivimab be in the Battle Against Covid-19?
A CRISPR Approach to Genetic Medicine
Dissecting the immune characteristics of severe COVID-19 responses
Antidepressant may prevent severe COVID-19, trial suggests
Rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown
A new data-driven model shows that wearing masks saves lives – and the earlier you start, the better
COVID-19 vaccine: how the 'mum test' can help ensure take-up
Interferon beta-1a candidate for COPD advances to PhIII to test its potential against Covid-19
With or without allergies, outcomes similar for hospitalized patients with COVID-19